This research was performed in accordance with the Partners Institutional Review Board (protocol no. 2011P000940 and no. 2018P001584). Written informed consent for specimen collection was obtained from all patients included in this study. PIK3CD mutations were initially identified on next-generation sequencing and confirmed by Sanger sequencing using primers PIK3CD_3_4F/R and PIK3CD_23F/R and polymerase chain reaction (PCR) conditions as previously described (19).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.